Disclosed is the use of oleacein to inhibit foam cell formation process by effective inhibition of oxLDL uptake by macrophages, particularly by reducing expression of macrophage scavenger receptors. Oleacein-comprising pharmaceutical preparations produced according to the invention are viable for use in the treatment and/or prevention of atherosclerosis, particularly in the prevention of early atherosclerotic lesions.
